Clinical Trials Overview

A clinical trial is a type of research study involving patients or healthy volunteers that is designed to evaluate whether a potential new treatment (that has not been approved by the Food and Drug Administration) is safe and effective. In some clinical trials, participants may be randomly assigned to receive the potential new treatment, an alternate treatment or a placebo (a compound that looks like the study drug but does not contain active ingredients). Your participation in a clinical trial contributes significantly to medical research and to the potential development of new treatment options for a disease or condition.

miRagen is actively enrolling the following clinical trials for patients with certain cancers or a history of keloids:

  • SOLAR, a Phase 2 clinical trial of cobomarsen (MRG-106) in patients with cutaneous T-cell lymphoma (CTCL), mycosis fungoides (MF) subtype
  • Phase 1 clinical trial of cobomarsen (MRG-106) in patients with adult T-cell leukemia/lymphoma (ATLL), chronic lymphocytic leukemia (CLL) and diffuse large B-cell lymphoma (DLBCL)
  • Phase 2 clinical trial of remlarsen (MRG-201) in participants with a history of keloids

For more information about miRagen clinical trials, please contact the miRagen Medical and Patient Liaison at (720) 643-5200.

If you are a patient enrolled in a miRagen clinical trial and you have questions regarding data privacy, please contact the miRagen Data Protection Officer (DPO) at (720) 643-5200.